Abstract:Purpose. NLRP3-associated autoinflammatory disease (NLRP3-AID) is characterized by gain-of-function variants in the NLRP3 gene. Since there are little literature focusing on pediatric NLRP3-AID in China, we aimed to elucidate the phenotypic and genotypic profiles of Chinese patients with NLRP3-AID. Methods. Patients with NLRP3-AID at three rheumatology centers in China were genotyped through whole exome sequencing or gene panel sequencing. Sanger sequencing was performed on all patients and their parents. Clinical phenotype, treatment, and prognosis were analyzed. Results. Nine patients with NLRP3-AID were enrolled between December 2014 and October 2022 with an average follow-up period exceeding 30 months. The median age of onset was 12 months, and 66.7% were younger than 3 years old. The diagnosis was significantly delayed and the median delay duration was 115 months. The patients most commonly presented with rash (100%), arthritis/arthralgia (88.9%), lymphadenopathy (88.9%), fever (77.8%), and growth retardation (44.4%). During acute attack, white blood cell, C-reactive protein, and/or erythrocyte sedimentation rate all increased in all cases, and inflammatory markers remained elevated beyond 7 days postfever resolution in 57.1% of patients (4/7). Two cases of chronic infantile neurological cutaneous articular syndrome (CINCA) had clubbed fingers, one with interstitial lung disease, a finding rarely reported. Treatment with glucocorticoids (77.8%) and biologic agents (33.3%) yielded 66% complete remission and 33% partial remission. Genetic analysis identified eight pathogenic NLRP3 missense mutations, including one novel mutation. Conclusions. Our study illuminated the distinct clinical and genetic features of Chinese NLRP3-AID patients, emphasizing the significance of early genetic screening. Despite delayed diagnosis, treatment primarily with glucocorticoids and biologic agents, led to favorable outcomes. Genetic heterogeneity, including a novel mutation, highlighted the complexity of NLRP3-AID in this population.

Clinical Study and PLA2G6 Mutation Screening Analysis in Chinese Patients with Infantile Neuroaxonal Dystrophy

Four novel rare mutations of PLA2G6 in Chinese population with Parkinson's disease.

The Clinical Characteristics and Molecular Genetics of Infantile Neuroaxonal Dystrophy: the Current Research Progress

Monozygotic Twins with Infantile Neuroaxonal Dystrophy: A Case Report and Literature Review

Mutation and Clinical Characteristics of Autosomal-Dominant Hereditary Spastic Paraplegias in China

The role of NOTCH2NLC in Parkinson's disease: A clinical, neuroimaging, and pathological study

A Novel Homozygous Mutation in PLA2G6 Gene Causes Infantile Neuroaxonal Dystrophy in a Case

Follow-Up Study of 25 Chinese Children with Pla2g6-Associated Neurodegeneration

Novel PLA2G6 Pathogenic Variants in Chinese Patients With PLA2G6-Associated Neurodegeneration

Neurodegeneration associated with genetic defects in phospholipase A(2)

Novel PLA2G6 mutations and clinical heterogeneity in Chinese cases with phospholipase A2-associated neurodegeneration.

Identification of Novel Compound Mutations in PLA2G6-Associated Neurodegeneration Patient with Characteristic MRI Imaging

Novel variants in AP4B1 cause spastic tetraplegia, moderate psychomotor development delay and febrile seizures in a Chinese patient: a case report

A systematic analysis of genotype–phenotype associations with PLA2G6

Infantile Neuroaxonal Dystrophy: Case Report and Review of Literature

Novel and recurrent PHGDH and PSAT1 mutations in Chinese patients with Neu-Laxova syndrome

Clinical and Genetic Spectrum of Nine Cases of NLRP3-Associated Autoinflammatory Disease (NLRP3-AID) and Identification of One Novel NLRP3 Mutation by Genetic Variation Analyses

Clinical and genetic study of SPG6 mutation in a Chinese family with hereditary spastic paraplegia

Pla2g6 Gene Mutation in Autosomal Recessive Early-Onset Parkinsonism in A Chinese Cohort

Clinical Characterization and Founder Effect Analysis in Chinese Patients with Phospholipase A2-Associated Neurodegeneration

Clinical and genetic study of twelve Chinese patients with Alexander disease